Results 141 to 150 of about 55,191 (264)

Macropinocytosis fuels osteoclast differentiation in bone-related diseases. [PDF]

J Orthop Translat
Gu M, Xue L, Ran S, Yuan Y, Zhai Q, Zhang H, Zhang H, Ji P.   +7 more
europepmc   +1 more source

Membrane‐type I metalloproteinase (MT1‐MMP): A key modifier of extracellular matrix microenvironment

The FEBS Journal, EarlyView.
MT1‐MMP: A cellular microenvironment modifier. MT1‐MMP is a major cellular microenvironment modifier, maintaining collagen homeostasis by degrading excess collagen (A), creating a migration path in motile cells such as cancer cells (B), modulating local microenvironmental signaling by cleaving transmembrane receptors (C), and destroying tissue ...
Yoshifumi Itoh, Masaki Inada
wiley   +1 more source

Correction: <i>Viscum coloratum</i> (Kom.) Nakai inhibits osteoclastogenesis in RANKL-induced osteoclast differentiation through the PI3K/AKT/mTOR pathway. [PDF]

Cytotechnology
Hao Z, Liu Y, Wang Y, Yang X, Pan Y, Chen Q, Zhang L, Kuang H, Li Y, Wang Y, Yang BY, Liu Y.   +11 more
europepmc   +1 more source

Intramuscular myxoma with chondroid features: two cases expanding the morphological spectrum

Histopathology, EarlyView.
Background Intramuscular myxoma is a benign mesenchymal tumour typically composed of bland spindle to stellate cells in abundant myxoid stroma and usually characterized by GNAS mutations. Chondroid matrix has not been previously reported in intramuscular myxoma.
Bethany Batson, Azfar Neyaz, Lucas Da Gama Lobo, Rana Naous, Stella J Lee, Ivy John   +5 more
wiley   +1 more source

Surfactin Inhibits Osteoclast Differentiation by Negatively Regulating the Elk1-AP-1-NFATc1 Axis. [PDF]

Biomedicines
Maruyama K, Koga A, Kodama Y, Yamasaki R, Nagai-Yoshioka Y, Miyamoto JJ, Kuroishi K, Gunjigake K, Kawamoto T, Ariyoshi W.   +9 more
europepmc   +1 more source

Outcomes of Root Canal Treatment in Patients With Autoimmune Disease: A Retrospective Case–Control Study

International Endodontic Journal, EarlyView.
ABSTRACT Aim The purpose of this study was to compare the outcome of nonsurgical root canal treatment (RCT) in patients with autoimmune diseases (AD) with the outcome in patients without AD. The null hypothesis was: there is no difference in the outcomes of RCT regardless of the patient group. Results were also compared among AD subgroups: inflammatory
Seoyeon Lee, Euiseong Kim, Hoiin Jung, Hyejin Kim, Sunil Kim   +4 more
wiley   +1 more source

Correction to "Mechanism of ITGB2 in Osteoclast Differentiation in Osteoarthritis". [PDF]

Cell Prolif
europepmc   +1 more source

AP39 suppresses osteoclast differentiation and neural factor expression under inflammatory condition. [PDF]

J Orthop Surg Res
Li P, Wang S, Lv Y, Wang Y.
europepmc   +1 more source

The Role of Neuropeptide Y in Dental Pulp: Balancing Neurogenic Inflammation and Pain Modulation

International Endodontic Journal, EarlyView.
ABSTRACT Background Dental pulp is a densely innervated, low‐compliance tissue in which neurogenic inflammation can rapidly escalate into oedema, raised intrapulpal pressure, microvascular compromise, and pain. While Substance P (SP) and Calcitonin gene‐related peptide (CGRP) are well‐established drivers of pulp vasodilation, the Neuroopeptide Y (NPY ...
Javier Caviedes‐Bucheli, Esteban Ulate, Hugo‐Roberto Munoz, Nestor Ríos‐Osorio   +3 more
wiley   +1 more source

C-X-C motif chemokine ligand 13 suppresses osteoclast differentiation via interference with RANKL-RANK interaction. [PDF]

Front Immunol
Ho TL, Lee KT, He YH, Thuong LHH, Achudhan D, Huang WC, Ko CY, Liu CL, Guo JH, Tang CH.   +9 more
europepmc   +1 more source